Please Wait.....
Report
Pulmonary Function Testing Devices Market By Product (Portable PFT Devices, Complete PFT Devices), By Test Type (Spirometry, Peak flow meter, Lung Volume Test, Gas Exchange Testing, Maximal Voluntary Ventilation, Others), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, Others), By End user (Hospital, Clinical laboratories, Diagnostic Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-09-01 I 341 Pages I Allied Market Research
Pulmonary function testing is a series of tests that can determine as well as measure the efficacy of inhaling and exhaling functions performed by the lungs. It plays a pivotal role in determining the efficient transfer of oxygen into the blood and helps in diagnosing certain types of lung diseases such as asthma, bronchitis, and emphysema, along with determining the cause of shortness of breath.
Some of the common types of pulmonary function tests are spirometry. Spirometry measures how much air a person can breathe in and out. It also measures how fast a person can empty the air out of the lungs. This test is done to check how well the oxygen moves from the lungs into the bloodstream.
The key factors that drive the growth of the market are the rise in the prevalence of lung cancer and lung-related disorders; rise in the geriatric population; and the increase in adoption of technologically advanced medical devices across the world. In addition, rise in the demand for minimally invasive tests for lung diseases across the key is the key factor which further boosts the market growth. For instance, according to the World Health Organization, in 2020, chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide. It was estimated that around 3.9 million people died due to COPD. Furthermore, increase in the geriatric population and the rise in the prevalence of chronic lung diseases has increased the demand pulmonary function testing devices for disease diagnosis across the world which further boost the market growth.
Moreover, increase in R&D activity for pulmonary function testing devices, and a rise in healthcare expenditures further boost the growth of market. However, the high cost of medical devices and a lack of awareness of pulmonary tests hamper the market growth. Conversely, the emerging healthcare market in developing countries is expected to provide a lucrative opportunity for the key players operating in the market during the forecast period.
The pulmonary function testing devices market is segmented on the basis of product, test type, application, end user, and region. On the basis of product, it is segmented into portable PFT devices and complete PFT systems. On the basis of test type, the market is segmented into spirometry, peak flow meter, lung volume test, gas exchange testing, maximal voluntary ventilation, and others. On the basis of application, it is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease and others. On the basis of end user, the market is segmented into hospitals, diagnostic centers, clinical laboratories and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America dominated pulmonary function testing devices in 2021 and is anticipated to remain dominant during the forecast period due to rise in healthcare expenditure and the presence of major players in the in this region.
Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population.
The key players that operate in the pulmonary function testing devices market are Chest M.I Inc, Clarity Medical Pvt. Ltd., Cosmed srl, Data Sciences International Inc, Eco Medics AG, Geratherm Medical AG, JK Medical System Pvt. Ltd., Medical Electronic Construction, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Morgan Scientific Inc, NDD Medical Technologies Inc, Omron Corporation, Pulm One Advanced Medical Devices Ltd., Schiller AG, Koko LLC, and Vyaire Medical Inc
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pulmonary function testing devices market analysis from 2021 to 2031 to identify the prevailing pulmonary function testing devices market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the pulmonary function testing devices market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global pulmonary function testing devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Portable PFT Devices
- Type
- Hardware
- Software
- Complete PFT Devices
- Type
- Hardware
- Software
By Test Type
- Spirometry
- Peak flow meter
- Lung Volume Test
- Gas Exchange Testing
- Maximal Voluntary Ventilation
- Others
By Application
- Chronic Obstructive Pulmonary Disease
- Asthma
- Chronic Shortness of Breath
- Restrictive Lung Disease
- Others
By End user
- Hospital
- Clinical laboratories
- Diagnostic Laboratories
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest Of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
- Key Market Players
- SCHILLER
- COSMED srl
- NSPIRE HEALTH INC
- MGC Diagnostics Corporation
- ndd Medizintechnik AG
- Morgan Scientific Inc.,
- Ganshorn Medizin Electronic
- Minato Holdings Inc
- CHEST M.I., Inc
- Medical Equipment Europe
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Portable PFT Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Portable PFT Devices Pulmonary Function Testing Devices Market by Type
4.2.4.1 Hardware Market size and forecast, by region
4.2.4.2 Software Market size and forecast, by region
4.3 Complete PFT Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Complete PFT Devices Pulmonary Function Testing Devices Market by Type
4.3.4.1 Hardware Market size and forecast, by region
4.3.4.2 Software Market size and forecast, by region
CHAPTER 5: PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Spirometry
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Peak flow meter
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Lung Volume Test
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Gas Exchange Testing
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Maximal Voluntary Ventilation
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Others
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
CHAPTER 6: PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Chronic Obstructive Pulmonary Disease
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Asthma
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Chronic Shortness of Breath
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Restrictive Lung Disease
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Others
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospital
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Clinical laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Diagnostic Laboratories
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product
8.2.2.1 North America Portable PFT Devices Pulmonary Function Testing Devices Market by Type
8.2.2.2 North America Complete PFT Devices Pulmonary Function Testing Devices Market by Type
8.2.3 North America Market size and forecast, by Test Type
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by End user
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product
8.2.6.1.2 Market size and forecast, by Test Type
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by End user
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product
8.2.6.2.2 Market size and forecast, by Test Type
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by End user
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product
8.2.6.3.2 Market size and forecast, by Test Type
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by End user
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product
8.3.2.1 Europe Portable PFT Devices Pulmonary Function Testing Devices Market by Type
8.3.2.2 Europe Complete PFT Devices Pulmonary Function Testing Devices Market by Type
8.3.3 Europe Market size and forecast, by Test Type
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by End user
8.3.6 Europe Market size and forecast, by country
8.3.6.1 France
8.3.6.1.1 Market size and forecast, by Product
8.3.6.1.2 Market size and forecast, by Test Type
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by End user
8.3.6.2 Germany
8.3.6.2.1 Market size and forecast, by Product
8.3.6.2.2 Market size and forecast, by Test Type
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by End user
8.3.6.3 Italy
8.3.6.3.1 Market size and forecast, by Product
8.3.6.3.2 Market size and forecast, by Test Type
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by End user
8.3.6.4 UK
8.3.6.4.1 Market size and forecast, by Product
8.3.6.4.2 Market size and forecast, by Test Type
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by End user
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product
8.3.6.5.2 Market size and forecast, by Test Type
8.3.6.5.3 Market size and forecast, by Application
8.3.6.5.4 Market size and forecast, by End user
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product
8.3.6.6.2 Market size and forecast, by Test Type
8.3.6.6.3 Market size and forecast, by Application
8.3.6.6.4 Market size and forecast, by End user
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product
8.4.2.1 Asia-Pacific Portable PFT Devices Pulmonary Function Testing Devices Market by Type
8.4.2.2 Asia-Pacific Complete PFT Devices Pulmonary Function Testing Devices Market by Type
8.4.3 Asia-Pacific Market size and forecast, by Test Type
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by End user
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product
8.4.6.1.2 Market size and forecast, by Test Type
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by End user
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product
8.4.6.2.2 Market size and forecast, by Test Type
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by End user
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product
8.4.6.3.2 Market size and forecast, by Test Type
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by End user
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product
8.4.6.4.2 Market size and forecast, by Test Type
8.4.6.4.3 Market size and forecast, by Application
8.4.6.4.4 Market size and forecast, by End user
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product
8.4.6.5.2 Market size and forecast, by Test Type
8.4.6.5.3 Market size and forecast, by Application
8.4.6.5.4 Market size and forecast, by End user
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product
8.4.6.6.2 Market size and forecast, by Test Type
8.4.6.6.3 Market size and forecast, by Application
8.4.6.6.4 Market size and forecast, by End user
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product
8.5.2.1 LAMEA Portable PFT Devices Pulmonary Function Testing Devices Market by Type
8.5.2.2 LAMEA Complete PFT Devices Pulmonary Function Testing Devices Market by Type
8.5.3 LAMEA Market size and forecast, by Test Type
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by End user
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product
8.5.6.1.2 Market size and forecast, by Test Type
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by End user
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product
8.5.6.2.2 Market size and forecast, by Test Type
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by End user
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product
8.5.6.3.2 Market size and forecast, by Test Type
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by End user
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product
8.5.6.4.2 Market size and forecast, by Test Type
8.5.6.4.3 Market size and forecast, by Application
8.5.6.4.4 Market size and forecast, by End user
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 SCHILLER
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 COSMED srl
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 NSPIRE HEALTH INC
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 MGC Diagnostics Corporation
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 ndd Medizintechnik AG
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Morgan Scientific Inc.,
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Ganshorn Medizin Electronic
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Minato Holdings Inc
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 CHEST M.I., Inc
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Medical Equipment Europe
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PORTABLE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 3. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PORTABLE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 6. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 7. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR COMPLETE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 8. PULMONARY FUNCTION TESTING DEVICES MARKET FOR COMPLETE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. GLOBAL COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 10. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 11. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 12. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 13. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SPIROMETRY, BY REGION, 2021-2031 ($MILLION)
TABLE 14. PULMONARY FUNCTION TESTING DEVICES MARKET FOR SPIROMETRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PEAK FLOW METER, BY REGION, 2021-2031 ($MILLION)
TABLE 16. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PEAK FLOW METER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR LUNG VOLUME TEST, BY REGION, 2021-2031 ($MILLION)
TABLE 18. PULMONARY FUNCTION TESTING DEVICES MARKET FOR LUNG VOLUME TEST, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR GAS EXCHANGE TESTING, BY REGION, 2021-2031 ($MILLION)
TABLE 20. PULMONARY FUNCTION TESTING DEVICES MARKET FOR GAS EXCHANGE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR MAXIMAL VOLUNTARY VENTILATION, BY REGION, 2021-2031 ($MILLION)
TABLE 22. PULMONARY FUNCTION TESTING DEVICES MARKET FOR MAXIMAL VOLUNTARY VENTILATION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 24. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 26. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 27. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR ASTHMA, BY REGION, 2021-2031 ($MILLION)
TABLE 29. PULMONARY FUNCTION TESTING DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC SHORTNESS OF BREATH, BY REGION, 2021-2031 ($MILLION)
TABLE 31. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC SHORTNESS OF BREATH, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR RESTRICTIVE LUNG DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 33. PULMONARY FUNCTION TESTING DEVICES MARKET FOR RESTRICTIVE LUNG DISEASE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 35. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 36. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 37. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HOSPITAL, BY REGION, 2021-2031 ($MILLION)
TABLE 38. PULMONARY FUNCTION TESTING DEVICES MARKET FOR HOSPITAL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 40. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 42. PULMONARY FUNCTION TESTING DEVICES MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 43. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 44. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 45. PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 47. NORTH AMERICA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. NORTH AMERICA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 49. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 50. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 51. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 53. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 54. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 55. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 56. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 59. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 63. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 64. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 65. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 66. EUROPE PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. EUROPE COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 68. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 69. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 71. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 72. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 74. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 75. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 78. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 82. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 83. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 86. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 87. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 90. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 94. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 97. ASIA-PACIFIC PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. ASIA-PACIFIC COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 99. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 100. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 101. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 102. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 103. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 104. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 105. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 106. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 107. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 108. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 109. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 110. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 111. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 112. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 113. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 114. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 115. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 116. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 117. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 118. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 119. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 120. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 121. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 122. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 123. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 124. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 125. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 126. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 127. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 128. LAMEA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 129. LAMEA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 130. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 131. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 133. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 134. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 135. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 136. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 137. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 138. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 139. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 140. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 141. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 142. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 143. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 144. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 145. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 146. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 147. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 148. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 149. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 150.SCHILLER: COMPANY SNAPSHOT
TABLE 151.SCHILLER: OPERATING SEGMENTS
TABLE 152.SCHILLER: PRODUCT PORTFOLIO
TABLE 153.SCHILLER: NET SALES,
TABLE 154.SCHILLER: KEY STRATERGIES
TABLE 155.COSMED SRL: COMPANY SNAPSHOT
TABLE 156.COSMED SRL: OPERATING SEGMENTS
TABLE 157.COSMED SRL: PRODUCT PORTFOLIO
TABLE 158.COSMED SRL: NET SALES,
TABLE 159.COSMED SRL: KEY STRATERGIES
TABLE 160.NSPIRE HEALTH INC: COMPANY SNAPSHOT
TABLE 161.NSPIRE HEALTH INC: OPERATING SEGMENTS
TABLE 162.NSPIRE HEALTH INC: PRODUCT PORTFOLIO
TABLE 163.NSPIRE HEALTH INC: NET SALES,
TABLE 164.NSPIRE HEALTH INC: KEY STRATERGIES
TABLE 165.MGC DIAGNOSTICS CORPORATION: COMPANY SNAPSHOT
TABLE 166.MGC DIAGNOSTICS CORPORATION: OPERATING SEGMENTS
TABLE 167.MGC DIAGNOSTICS CORPORATION: PRODUCT PORTFOLIO
TABLE 168.MGC DIAGNOSTICS CORPORATION: NET SALES,
TABLE 169.MGC DIAGNOSTICS CORPORATION: KEY STRATERGIES
TABLE 170.NDD MEDIZINTECHNIK AG: COMPANY SNAPSHOT
TABLE 171.NDD MEDIZINTECHNIK AG: OPERATING SEGMENTS
TABLE 172.NDD MEDIZINTECHNIK AG: PRODUCT PORTFOLIO
TABLE 173.NDD MEDIZINTECHNIK AG: NET SALES,
TABLE 174.NDD MEDIZINTECHNIK AG: KEY STRATERGIES
TABLE 175.MORGAN SCIENTIFIC INC.,: COMPANY SNAPSHOT
TABLE 176.MORGAN SCIENTIFIC INC.,: OPERATING SEGMENTS
TABLE 177.MORGAN SCIENTIFIC INC.,: PRODUCT PORTFOLIO
TABLE 178.MORGAN SCIENTIFIC INC.,: NET SALES,
TABLE 179.MORGAN SCIENTIFIC INC.,: KEY STRATERGIES
TABLE 180.GANSHORN MEDIZIN ELECTRONIC: COMPANY SNAPSHOT
TABLE 181.GANSHORN MEDIZIN ELECTRONIC: OPERATING SEGMENTS
TABLE 182.GANSHORN MEDIZIN ELECTRONIC: PRODUCT PORTFOLIO
TABLE 183.GANSHORN MEDIZIN ELECTRONIC: NET SALES,
TABLE 184.GANSHORN MEDIZIN ELECTRONIC: KEY STRATERGIES
TABLE 185.MINATO HOLDINGS INC: COMPANY SNAPSHOT
TABLE 186.MINATO HOLDINGS INC: OPERATING SEGMENTS
TABLE 187.MINATO HOLDINGS INC: PRODUCT PORTFOLIO
TABLE 188.MINATO HOLDINGS INC: NET SALES,
TABLE 189.MINATO HOLDINGS INC: KEY STRATERGIES
TABLE 190.CHEST M.I., INC: COMPANY SNAPSHOT
TABLE 191.CHEST M.I., INC: OPERATING SEGMENTS
TABLE 192.CHEST M.I., INC: PRODUCT PORTFOLIO
TABLE 193.CHEST M.I., INC: NET SALES,
TABLE 194.CHEST M.I., INC: KEY STRATERGIES
TABLE 195.MEDICAL EQUIPMENT EUROPE: COMPANY SNAPSHOT
TABLE 196.MEDICAL EQUIPMENT EUROPE: OPERATING SEGMENTS
TABLE 197.MEDICAL EQUIPMENT EUROPE: PRODUCT PORTFOLIO
TABLE 198.MEDICAL EQUIPMENT EUROPE: NET SALES,
TABLE 199.MEDICAL EQUIPMENT EUROPE: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.PULMONARY FUNCTION TESTING DEVICES MARKET SEGMENTATION
FIGURE 2.PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031
FIGURE 3.PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.PULMONARY FUNCTION TESTING DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.PULMONARY FUNCTION TESTING DEVICES MARKET,BY PRODUCT,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 15.PULMONARY FUNCTION TESTING DEVICES MARKET,BY TEST TYPE,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SPIROMETRY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PEAK FLOW METER PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF LUNG VOLUME TEST PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF GAS EXCHANGE TESTING PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MAXIMAL VOLUNTARY VENTILATION PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 22.PULMONARY FUNCTION TESTING DEVICES MARKET,BY APPLICATION,2021(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ASTHMA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CHRONIC SHORTNESS OF BREATH PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF RESTRICTIVE LUNG DISEASE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 28.PULMONARY FUNCTION TESTING DEVICES MARKET,BY END USER,2021(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 33.PULMONARY FUNCTION TESTING DEVICES MARKET BY REGION,2021
FIGURE 34.U.S. PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 35.CANADA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 36.MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 37.FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 38.GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 39.ITALY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 40.UK PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 41.SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 42.REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 43.JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 44.CHINA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 45.INDIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 46.AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 47.SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 48.REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 49.BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 50.SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 51.SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 52.REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 53. TOP WINNING STRATEGIES, BY YEAR
FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 56.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 57.COMPETITIVE DASHBOARD
FIGURE 58.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 59.SCHILLER.: NET SALES ,($MILLION)
FIGURE 60.COSMED SRL.: NET SALES ,($MILLION)
FIGURE 61.NSPIRE HEALTH INC.: NET SALES ,($MILLION)
FIGURE 62.MGC DIAGNOSTICS CORPORATION.: NET SALES ,($MILLION)
FIGURE 63.NDD MEDIZINTECHNIK AG.: NET SALES ,($MILLION)
FIGURE 64.MORGAN SCIENTIFIC INC.,.: NET SALES ,($MILLION)
FIGURE 65.GANSHORN MEDIZIN ELECTRONIC.: NET SALES ,($MILLION)
FIGURE 66.MINATO HOLDINGS INC.: NET SALES ,($MILLION)
FIGURE 67.CHEST M.I., INC.: NET SALES ,($MILLION)
FIGURE 68.MEDICAL EQUIPMENT EUROPE.: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security